BUZZ-Tempus AI stretches rally as co and SoftBank launch AI healthcare JV ** Shares of genetics testing firm Tempus AI TEM.O , backed by SoftBank 9984.T , up ~7% early Thurs, adding to ~10% gain in prior session ** SoftBank has launched joint venture with Tempus aiming to analyze personal medical data with artificial intelligence to come up with treatment recommendations, CEO Masayoshi Son told a briefing in Tokyo on Thurs ** The cos expected to each put $93 mln into the JV, which is anticipated

BUZZ-SoftBank-backed Tempus AI sinks to new post-IPO lows ** Shares of Tempus AI TEM.O , genetics testing firm backed by SoftBank 9984.T , down 2.7% at $24.63 on Tues and now off ~33% from IPO price ** Stock drops as much as 9.6% to $22.89 on the session ** TEM shares on track to fall for fifth time in past six days since closing up nearly 9% at $40.25 in their Jun 14 debut ** Tempus, founded in 2015 and has yet to turn a profit, raised ~$411 mln by selling 11.1 mln shares at $37 , top end of ma

BUZZ-SoftBank-backed Tempus AI extends slump after strong listing Updates ** Shares of SoftBank 9984.T -backed Tempus AI TEM.O tumble as much as ~ 21 % to slump for the third straight session ** The genetics testing firm, led by Groupon GRPN.O co-founder Eric Lefkofsky, closed up 8.8% at $40.25 on its market debut on Friday, June 14 ** Shares fell 9.4% on Monday and 16.9% on Tuesday ** Tempus, which was founded in 2015 and is yet to post a profit, raised $410.7 mln by selling 11.1 mln shares at

BUZZ-SoftBank-backed Tempus AI extends slump after strong listing ** Shares of SoftBank 9984.T -backed Tempus AI TEM.O tumble as much as 20% to slump for the third straight session ** The genetics testing firm, led by Groupon GRPN.O co-founder Eric Lefkofsky, closed up 8.8% at $40.25 on its market debut on Friday, June 14 ** Shares fell 9.4% on Mon

BUZZ-SoftBank-backed Tempus AI tumbles well below IPO price ** Shares of Tempus AI TEM.O , genetics testing firm backed by SoftBank 9984.T , down 16% at $30.65 on Tues in their third day of trading ** TEM, which shed ~9% on Mon, tumbles as low as $30.31 on the session ** Stock now >17% below $37 IPO price set late Thurs after co raised ~$411 mln by selling 11.1 mln shares ** TEM traded as high as $43.88 in debut on Fri before closing at $40.25 ** Co led by Groupon GRPN.O co-founder Eric Lefkofsk

IBM settles lawsuit against Rakuten over e-commerce patents By Blake Brittain June 17 (Reuters) - International Business Machines Corp IBM.N has settled a lawsuit accusing Japan's Rakuten 4755.T of infringing IBM patents related to e-commerce technology, Delaware federal court records showed on Monday. U.S. District Judge Gregory Williams said in an oral order that he was "pleased to hear that the parties have reached an agreement to settle this case," according to an entry on the court's docket

UPDATE 1-Tempus AI prices US IPO at over $6 bln valuation Updates with details in paragraph 2,3 and background in paragraph 4,5 June 13 (Reuters) - SoftBank Group-backed 9984.T Tempus AI set the pricing of its U.S. initial public offering at $37 per share on Thursday, aiming to raise $410.7 million. The genetics-testing company priced its IPO at the higher end of is targeted range of $35 to $37, valuing the firm at about $6.10 billion, based on the outstanding shares listed in its filing with th

UPDATE 2-SoftBank-backed Tempus AI seeks up to $6.1 bln valuation in US IPO Adds background and details on competitors, customers and funding in paragraphs 4-10 June 5 (Reuters) - Tempus AI, backed by Japanese tech investment firm SoftBank Group 9984.T , is targeting a valuation of up to $6.10 billion for its U.S. initial public offering, nearly three years after the genetics-testing company laid the ground for its listing.

BREAKINGVIEWS-Precision-medicine IPO deserves Groupon discount The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Robert Cyran NEW YORK, May 31 (Reuters Breakingviews) - Personalized cancer treatments developed using genetic data crunched by artificial intelligence under the watch of a board that includes a Nobel laureate is the sort of business that should be an easy sell in today’s stock market.

BUZZ-U.S. STOCKS ON THE MOVE-H&R Block, McDonald, Groupon Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were mixed on Friday, but looked on track for weekly gains ahead of key inflation readings next week that could provide more clues on how soon the Federal Reserve will start cutting interest rates.

BUZZ-Groupon shares surge 30% after qtrly report exceeds expectations ** Shares of Groupon GRPN.O surge >30% on Fri, on track for biggest daily pct gain since Mar 2021, after e-commerce marketplace late Thurs reported Q1 rev above LSEG consensus expectations ** Stock last up 31% at $13.76 ** Rev in qtr of $123.1 mln, up 1% yr/yr, topped avg analyst

BRIEF-Groupon Q1 Revenue USD 123.1 Million May 09 (Reuters) - Groupon Q1 adjusted EBITDA USD 19.5 million. Q1 gross profit USD 110.6 million Q1 billings USD 381.1 million Q1 net income USD -11.5 million

Groupon Inc expected to post earnings of 5 cents a share - Earnings Preview Groupon Inc GRPN.OQ GRPN.O is expected to show a fall in quarterly revenue when it reports results on May 9 for the period ending March 31 2024 The Chicago Illinois-based company is expected to report a 3.4% decrease in revenue to $117.45 million from $121.61 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on March 15 2024, for the period ended March 31, was

U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Parker-Hannifin, Quaker Houghton May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Berkshire Hathaway, Parker-Hannifin and Quaker Houghton, on Monday. HIGHLIGHTS * Berkshire Hathaway BRKa.N : KBW raises target price to $660,000 from $645,000 * Essex Property Trust Inc ESS.N : Piper Sandler raises target price to $315 from $291 * Parker-Hannifin Corp PH.N : Jefferies cuts